Tell us about your search experience on the TGA website - complete our short survey
Topics
- COVID-19 (95)
- Advertising (74)
- COVID-19 vaccines (58)
- Prescription medicines (29)
- Medical devices (19)
- Regulatory compliance (18)
- Alert/Advisory (14)
- Medicines safety (9)
- In Vitro Diagnostic medical devices (IVDs) (6)
- Manufacturing (6)
- Disinfectants/Sterilants (5)
- Medicines (5)
- OTC medicines (3)
- Labelling and packaging (2)
- Shortages (2)
- Biologicals (1)
- Medicinal cannabis hub (1)
- Safety (1)
- Scheduling (1)
- Unapproved therapeutic goods (1)
Collection content
287 result(s) found, displaying 1 to 10
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 27-01-2023Information about the TGA's safety monitoring of COVID-19 vaccines.
- Media releasesTGA grants provisional approval to Pfizer’s COVID-19 bivalent (COMIRNATY Original/Omicron BA.4-5 COVID-19 vaccine) booster dose vaccineThis is the first vaccine provisionally approved by the TGA that is designed to specifically target the Omicron variants BA.4/BA.5 and follows provisional approval of the Pfizer BA.1 Omicron/original bivalent vaccine.
- Media releasesTGA commences evaluation of Moderna COVID-19 vaccine (SPIKEVAX) for potential transition to full registrationThe TGA has commenced evaluation of an application from Moderna Australia Pty Ltd to transition its COVID-19 vaccine, SPIKEVAX, to full registration for the immunisation of individuals 6 years and over, and as a booster dose for individuals aged 12 years and older.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report – 12-01-2023Information about the TGA's safety monitoring of COVID-19 vaccines.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 22-12-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 15-12-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 01-12-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 17-11-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- Media releasesTGA grants provisional determination to Pfizer’s COVID-19 bivalent (COMIRNATY BIVALENT OMICRON BA.4/BA.5) booster dose vaccineThe TGA has granted a provisional determination to Pfizer's bivalent COVID-19 vaccine candidate: tozinameran & famtozinameran (COMIRNATY BIVALENT OMICRON BA.4/BA.5 COVID-19 VACCINE).
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 03-11-2022Information about the TGA's safety monitoring of COVID-19 vaccines.